VALUATIONS remain undemanding. At price earnings ratios (PEs) of
17 times for 2004 and 14 times for 2005, Hyflux trades at a discount
to its global peers (prospective PEs of 14.9 to 47.5 times). We
raise our target price to $2.62, based on a 0.8 times price earnings
to growth ratio (PEG), or 2004 PE of 25.8 times. Reiterate OUTPERFORM
recommendation.